Paper Details
- Home
- Paper Details
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Author: AblijHans Christiaan, DelfosNathalie Manon, KosterTed, LeytenEliane Madeleine Sophie, StalenhoefJanneke Evelyne, WilsonDarius Cameron, van 't WoutJohannes Jan Willem, van DisselJaap Tamino, van NieuwkoopCees, van der ReijdenTanny J K, van der StarreWillize Elizabeth
Original Abstract of the Article :
A reduction in duration of antibiotic therapy is crucial in minimizing the development of antimicrobial resistance, drug-related side effects and health care costs. The minimal effective duration of antimicrobial therapy for febrile urinary tract infections (fUTI) remains a topic of uncertainty, esp...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376649/
データ提供:米国国立医学図書館(NLM)
Febrile Urinary Tract Infection: A Desert Storm in the Body
Urinary tract infections (UTIs), a common and often painful condition, are like desert storms, disrupting the body's delicate balance. This study, like a team of researchers seeking to navigate the intricacies of infection management, investigates the use of biomarkers, like guiding beacons, to optimize antibiotic treatment for febrile UTIs, infections accompanied by fever. The study focuses on three key biomarkers—procalcitonin, mid-regional proadrenomedullin, and C-reactive protein—examining their predictive value for treatment outcomes.
Biomarkers: A New Map in the Desert of Infection Management
The study's findings, like a well-defined map leading to a safe passage, suggest that these biomarkers can provide valuable information for guiding antibiotic treatment decisions for febrile UTIs. By monitoring changes in biomarker levels, clinicians can potentially shorten the duration of antibiotic therapy, minimizing the risk of antibiotic resistance and side effects, while ensuring optimal patient outcomes.
Navigating the Desert of Infection: A More Precise Approach
This research, like a seasoned traveler with a keen understanding of the desert landscape, offers a more precise and individualized approach to managing febrile UTIs. The findings highlight the potential of biomarkers to guide antibiotic treatment decisions, potentially leading to shorter treatment durations, improved outcomes, and reduced side effects. This is a significant step towards more efficient and effective infection management.
Dr. Camel's Conclusion
This study, like a well-equipped caravan navigating a challenging terrain, emphasizes the importance of personalized medicine in infection management. The findings suggest that biomarkers can be valuable tools for optimizing antibiotic therapy, leading to better patient outcomes and potentially reducing the emergence of antibiotic resistance.
Date :
- Date Completed 2019-04-01
- Date Revised 2020-02-25
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.